ADUSHealthcare · Medical Care FacilitiesThe 14 Wall Street analysts covering Addus HomeCare Corp. hold a median 12-month price target of $137 — +17.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 96 of 100 as at 14 Oct 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Addus HomeCare Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (93): The share price has been relatively steady.
Accruals (64): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (34): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ADUS, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +17.5% from it.
Of the 20 most recent actions, 2 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 14 Sept 2026 | B of A Securities | Downgrade | Neutral | $140 → $125 |
| 5 Aug 2026 | RBC Capital | Maintains | Outperform | $130 → $134 |
| 5 Aug 2026 | RBC Capital | Maintains | Outperform | — |
| 9 July 2026 | Barclays | Maintains | Underweight | $92 → $96 |
| 9 July 2026 | Barclays | Maintains | Underweight | — |
| 18 May 2026 | Citizens | Reiterates | Market Outperform | — |
| 15 May 2026 | Barclays | Maintains | Underweight | — |
| 6 May 2026 | Citizens | Maintains | Market Outperform | — |
| 25 Mar 2026 | Barclays | Maintains | Underweight | — |
| 25 Feb 2026 | Stephens & Co. | Maintains | Overweight | — |
| 24 Feb 2026 | Barclays | Maintains | Underweight | — |
| 13 Nov 2025 | BMO Capital | Initiates | Market Perform | — |
| 7 Nov 2025 | RBC Capital | Maintains | Outperform | — |
| 5 Nov 2025 | TD Cowen | Maintains | Buy | — |
| 4 Nov 2025 | Barclays | Maintains | Underweight | — |
| 3 Sept 2025 | Stephens & Co. | Reiterates | Overweight | — |
| 2 Sept 2025 | UBS | Initiates | Buy | — |
| 22 Aug 2025 | RBC Capital | Maintains | Outperform | — |
| 19 Aug 2025 | Barclays | Maintains | Underweight | — |
| 6 Aug 2025 | TD Cowen | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ADUS appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 14 Oct 2026, Addus HomeCare Corp. returned +1.8% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 37% of US stocks
Cheaper than 59% of US stocks
Cheaper than 47% of US stocks
Cheaper than 27% of US stocks
Higher than 47% of US stocks
Higher than 62% of US stocks
Higher than 37% of US stocks
Higher than 64% of US stocks
Higher than 65% of US stocks
Higher than 63% of US stocks
Higher than 82% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Addus HomeCare Corp. has a market value of $2.1B and an enterprise value of $2.1B.
Revenue in the twelve months to 30 June 2026: $1.5B. The latest quarter grew 8.0% year on year.
Net income over the same four quarters: $105.3M, a 7.1% net margin.
Diluted earnings per share, trailing twelve months: $5.67.
Free cash flow in the twelve months to 30 June 2026: $154.8M.
Trailing P/E: 20.1×; forward P/E: 15.2× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Addus HomeCare Corp. employs 5,982 people — $247K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Addus HomeCare Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Addus HomeCare said it will report third-quarter 2026 earnings after the market close on November 3, 2026. The company will hold a conference call on November 4 at 9:00 a.m. Eastern Time, with CEO Dirk Allison and CFO Brian Poff participating.
Why it matters — ADUS watchers can note the scheduled dates for the company’s quarterly results and management call.
Addus HomeCare announced a definitive agreement to acquire the personal care division of AccentCare, excluding its New York operations and its hospice and home health businesses, for an anticipated purchase price of approximately $275.0 million after customary adjustments.
Why it matters — This acquisition would expand Addus's personal care services footprint outside New York, potentially broadening its home care operations.
Addus HomeCare announced that CFO Brian Poff and Interim COO Brad Bickham will participate in the 2026 Jefferies Healthcare Services and Technology Conference, scheduled for September 14-15, 2026, in Nashville, Tennessee. A live broadcast and replay of the company's presentation will be available.
Why it matters — The conference participation gives ADUS executives a platform to present the company's business to healthcare investors and analysts.
Addus HomeCare Corporation reached a significant support level, and its 50-day simple moving average broke out above its 200-day moving average, a technical pattern known as a "golden cross." According to Zacks Investment Research, this could make the stock a good pick from a technical perspective.
Why it matters — A golden cross signal at a key support level is a commonly watched technical indicator that Addus HomeCare watchers may track as a marker of momentum.
Addus HomeCare announced that Heather Dixon has left her role as President and Chief Operating Officer, and former President and COO Brad Bickham has returned as interim COO for a one-year period.
Why it matters — A sudden leadership change in a key executive role, even with an experienced interim replacement, can signal organizational disruption that investors and analysts will monitor closely.
The 14 Wall Street analysts covering Addus HomeCare Corp. have a median 12-month price target of $137, with estimates ranging from $96 to $155. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 14 analysts covering Addus HomeCare Corp., 11 rate it a Buy, 2 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Addus HomeCare Corp. 96 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 14 Oct 2026, Addus HomeCare Corp. ranks 96 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (93 of 100).
No one can know that. What the data says: the median 12-month target from 14 analysts implies +17.5% from the last close, and Ticker Nerd's factor model ranks Addus HomeCare Corp. 96 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Addus HomeCare Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ADUS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $96 to $155 over the next 12 months.
Addus HomeCare Corp. returned +1.8% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Addus HomeCare Corporation is a U.S. healthcare services company focused on home-based care for elderly, chronically ill, disabled, and medically fragile individuals.
The most recent item we track (Business Wire, 13 Oct 2026): "Addus HomeCare Announces Third Quarter 2026 Earnings Release and Conference Call". Addus HomeCare said it will report third-quarter 2026 earnings after the market close on November 3, 2026. The company will hold a conference call on November 4 at 9:00 a.m. Eastern Time, with CEO Dirk Allison and CFO Brian Poff participating.
Addus HomeCare Corporation is a U.S. healthcare services company focused on home-based care for elderly, chronically ill, disabled, and medically fragile individuals. Addus HomeCare Corporation provides personal care, hospice, and home health services designed to support daily living, comfort, and clinical needs in the home setting. Its personal care services include non-medical assistance with activities such as bathing, grooming, dressing, meal support, and medication reminders, while its hospice and home health offerings address end-of-life support and medically supervised care after illness or hospitalization. The company serves patients through a broad network of locations across multiple states and works with government agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare Corporation plays an important role in the home care market by helping clients remain in familiar surroundings while receiving essential support services.
CEO Mr. R. Dirk Allison CPA · 5,982 employees · United States · https://www.addus.com
